Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interleukin-17 signaling influences CD8+ T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cells.
Rodriguez C, Araujo Furlan CL, Tosello Boari J, Bossio SN, Boccardo S, Fozzatti L, Canale FP, Beccaria CG, Nuñez NG, Ceschin DG, Piaggio E, Gruppi A, Montes CL, Acosta Rodríguez EV. Rodriguez C, et al. Among authors: boccardo s. Oncoimmunology. 2023 Oct 5;12(1):2261326. doi: 10.1080/2162402X.2023.2261326. eCollection 2023. Oncoimmunology. 2023. PMID: 37808403 Free PMC article.
Limited Foxp3+ Regulatory T Cells Response During Acute Trypanosoma cruzi Infection Is Required to Allow the Emergence of Robust Parasite-Specific CD8+ T Cell Immunity.
Araujo Furlan CL, Tosello Boari J, Rodriguez C, Canale FP, Fiocca Vernengo F, Boccardo S, Beccaria CG, Adoue V, Joffre O, Gruppi A, Montes CL, Acosta Rodriguez EV. Araujo Furlan CL, et al. Among authors: boccardo s. Front Immunol. 2018 Nov 5;9:2555. doi: 10.3389/fimmu.2018.02555. eCollection 2018. Front Immunol. 2018. PMID: 30455700 Free PMC article.
CD39 expression by regulatory T cells drives CD8+ T cell suppression during experimental Trypanosoma cruzi infection.
Araujo Furlan CL, Boccardo S, Rodriguez C, Robson SC, Gruppi A, Montes CL, Acosta Rodríguez EV. Araujo Furlan CL, et al. Among authors: boccardo s. bioRxiv [Preprint]. 2023 Sep 16:2023.09.14.557792. doi: 10.1101/2023.09.14.557792. bioRxiv. 2023. Update in: PLoS Pathog. 2024 Apr 29;20(4):e1012191. doi: 10.1371/journal.ppat.1012191 PMID: 37745571 Free PMC article. Updated. Preprint.
Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer.
Coco S, Boccardo S, Mora M, Fontana V, Vanni I, Genova C, Alama A, Salvi S, Dal Bello MG, Bonfiglio S, Rijavec E, Sini C, Barletta G, Biello F, Carli F, Cavalieri Z, Burrafato G, Longo L, Ballestrero A, Grossi F. Coco S, et al. Among authors: boccardo s. Clin Breast Cancer. 2021 Jun;21(3):218-230.e6. doi: 10.1016/j.clbc.2020.09.001. Epub 2020 Sep 6. Clin Breast Cancer. 2021. PMID: 33008754
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer.
Ottonello S, Genova C, Cossu I, Fontana V, Rijavec E, Rossi G, Biello F, Dal Bello MG, Tagliamento M, Alama A, Coco S, Boccardo S, Vanni I, Ferlazzo G, Moretta L, Grossi F, Mingari MC, Carrega P, Pietra G. Ottonello S, et al. Among authors: boccardo s. Front Immunol. 2020 Feb 7;11:125. doi: 10.3389/fimmu.2020.00125. eCollection 2020. Front Immunol. 2020. PMID: 32117275 Free PMC article.
57 results